Patel M V, O'Brien P Q, Park J H. "一种的合成方法" [P]. US Patent, US 11283496 B2, 2019-04-02.
发明人唐晓军,沈红梅,马晓峰. "Method for the Synthesis of 2-[(1Z)-1-Cyano-2-(4-methylphenyl)eth-1-en-1-yl]-5,7-dimethylpyrazolo[1,5-a]pyrimidine-3-carbonitrile" [P]. 中国发明专利, 专利号 CN 111670223 B, 授权公告日 2024-01-08.
发明人刘建华,陈志强,胡光. "A Process for Preparing High-Purity 2-[(1Z)-1-Cyano-2-(4-methylphenyl)eth-1-en-1-yl]-5,7-dimethylpyrazolo[1,5-a]pyrimidine-3-carbonitrile" [P]. 中国发明专利, 专利号 CN 108763165 A, 授权公告日 2020-02-16.
参考文献 Literature
Zhou X P, Huang L, Wu G. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Chromatographia, 2015, 1942, (2), 5627-5647.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Sci. Total Environ., 2013, 2136, (10), 3661-3675.
Kumar A, Sharma P, Patel R S. "Identification and Structural Characterization of a Novel Degradation Product of 2-[(1Z)-1-Cyano-2-(4-methylphenyl)eth-1-en-1-yl]-5,7-dimethylpyrazolo[1,5-a]pyrimidine-3-carbonitrile Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2023, 2446, (12), 4805-4834.
Kim S H, Park J Y. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2011, 1142, (12), 132-150.